Cargando…

Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study’s goal was to evaluate cognitive performance and risk factors for cognitive decline in this population. METHODS: Prospective observational study was conducted with 400 T2DM adults, of whom, during...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Faria, Ana Cristina Ravazzani, Dall’Agnol, Joceline Franco, Gouveia, Aline Maciel, de Paiva, Clara Inácio, Segalla, Victoria Chechetto, Baena, Cristina Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327152/
https://www.ncbi.nlm.nih.gov/pubmed/35897033
http://dx.doi.org/10.1186/s13098-022-00872-3
_version_ 1784757445697994752
author de Almeida Faria, Ana Cristina Ravazzani
Dall’Agnol, Joceline Franco
Gouveia, Aline Maciel
de Paiva, Clara Inácio
Segalla, Victoria Chechetto
Baena, Cristina Pellegrino
author_facet de Almeida Faria, Ana Cristina Ravazzani
Dall’Agnol, Joceline Franco
Gouveia, Aline Maciel
de Paiva, Clara Inácio
Segalla, Victoria Chechetto
Baena, Cristina Pellegrino
author_sort de Almeida Faria, Ana Cristina Ravazzani
collection PubMed
description BACKGROUND: Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study’s goal was to evaluate cognitive performance and risk factors for cognitive decline in this population. METHODS: Prospective observational study was conducted with 400 T2DM adults, of whom, during routine baseline and follow-up appointments, had socio-demographic, clinical, and laboratory data collected, and underwent physical examination, screening for depression symptoms (Patient Health Questionaire-9-PHQ-9), and cognitive tests: Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A/B, and Word Memory Tests. Each cognitive test score was converted to a z-score and its average resulted in a new variable called Global Cognitive z-Score [GCS(z)]. Averages of the cognitive test scores and GCS(z) at both moments were compared by the Student’s T-Test for paired samples. Multivariate binary logistic regression models were built to assess the association of GCS(z) < zero with risk factors for cognitive decline at the baseline and follow-up. RESULTS: After exclusions, 251 patients were eligible, being 56.6% female, mean age of 61.1 (± 9.8) years, 12.6 (± 8.9) years of DM duration, and 7.6 (± 4.2) years of school education. Follow-up had 134 patients reevaluated and took place after a mean of 18.4(± 5.0) months. Eleven (14%) patients with a GCS(z) ≥ 0 at baseline turned into a GCS(z) < 0 at follow-up. There were no significant differences between the means of cognitive test scores and GCS(z) at the two evaluation moments. At the baseline, the multivariate logistic regression model identified five risk factors associated with GCS(z) < zero: age ≥ 65 years, schooling ≤ 6 years, arterial hypertension, depression symptoms, and diabetic retinopathy (DR), with odds ratio (OR) and 95% confidence interval (CI95%) respectively: 5.46 (2.42–12.34); 12.19 (5.62–26.46); 2.55 (0.88–7.39); 3.53 (1.55–8.07) e 2.50 (1.18–5.34). At follow-up, the risk factors for GCS(z) < zero were: schooling ≤ 6 years, DM duration ≥ 10 years, depression symptoms, arterial hypertension, and cardiovascular disease (CVD), OR and CI95% respectively: 10.15 (3.68–28.01); 2.68 (0.96–7.48); 4.92 (1.77–13.70); 7.21 (1.38–35.71) e 5.76 (1.93–17.18). CONCLUSIONS: Based on our results, cognitive evaluation and follow-up should be incorporated on the routine of T2DM patients, especially for those with advanced age, low education level, prolonged DM duration, arterial hypertension, depression symptoms, CVD, and DR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00872-3.
format Online
Article
Text
id pubmed-9327152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93271522022-07-28 Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study de Almeida Faria, Ana Cristina Ravazzani Dall’Agnol, Joceline Franco Gouveia, Aline Maciel de Paiva, Clara Inácio Segalla, Victoria Chechetto Baena, Cristina Pellegrino Diabetol Metab Syndr Research BACKGROUND: Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study’s goal was to evaluate cognitive performance and risk factors for cognitive decline in this population. METHODS: Prospective observational study was conducted with 400 T2DM adults, of whom, during routine baseline and follow-up appointments, had socio-demographic, clinical, and laboratory data collected, and underwent physical examination, screening for depression symptoms (Patient Health Questionaire-9-PHQ-9), and cognitive tests: Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A/B, and Word Memory Tests. Each cognitive test score was converted to a z-score and its average resulted in a new variable called Global Cognitive z-Score [GCS(z)]. Averages of the cognitive test scores and GCS(z) at both moments were compared by the Student’s T-Test for paired samples. Multivariate binary logistic regression models were built to assess the association of GCS(z) < zero with risk factors for cognitive decline at the baseline and follow-up. RESULTS: After exclusions, 251 patients were eligible, being 56.6% female, mean age of 61.1 (± 9.8) years, 12.6 (± 8.9) years of DM duration, and 7.6 (± 4.2) years of school education. Follow-up had 134 patients reevaluated and took place after a mean of 18.4(± 5.0) months. Eleven (14%) patients with a GCS(z) ≥ 0 at baseline turned into a GCS(z) < 0 at follow-up. There were no significant differences between the means of cognitive test scores and GCS(z) at the two evaluation moments. At the baseline, the multivariate logistic regression model identified five risk factors associated with GCS(z) < zero: age ≥ 65 years, schooling ≤ 6 years, arterial hypertension, depression symptoms, and diabetic retinopathy (DR), with odds ratio (OR) and 95% confidence interval (CI95%) respectively: 5.46 (2.42–12.34); 12.19 (5.62–26.46); 2.55 (0.88–7.39); 3.53 (1.55–8.07) e 2.50 (1.18–5.34). At follow-up, the risk factors for GCS(z) < zero were: schooling ≤ 6 years, DM duration ≥ 10 years, depression symptoms, arterial hypertension, and cardiovascular disease (CVD), OR and CI95% respectively: 10.15 (3.68–28.01); 2.68 (0.96–7.48); 4.92 (1.77–13.70); 7.21 (1.38–35.71) e 5.76 (1.93–17.18). CONCLUSIONS: Based on our results, cognitive evaluation and follow-up should be incorporated on the routine of T2DM patients, especially for those with advanced age, low education level, prolonged DM duration, arterial hypertension, depression symptoms, CVD, and DR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00872-3. BioMed Central 2022-07-27 /pmc/articles/PMC9327152/ /pubmed/35897033 http://dx.doi.org/10.1186/s13098-022-00872-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
de Almeida Faria, Ana Cristina Ravazzani
Dall’Agnol, Joceline Franco
Gouveia, Aline Maciel
de Paiva, Clara Inácio
Segalla, Victoria Chechetto
Baena, Cristina Pellegrino
Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title_full Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title_fullStr Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title_full_unstemmed Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title_short Risk factors for cognitive decline in type 2 diabetes mellitus patients in Brazil: a prospective observational study
title_sort risk factors for cognitive decline in type 2 diabetes mellitus patients in brazil: a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327152/
https://www.ncbi.nlm.nih.gov/pubmed/35897033
http://dx.doi.org/10.1186/s13098-022-00872-3
work_keys_str_mv AT dealmeidafariaanacristinaravazzani riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy
AT dallagnoljocelinefranco riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy
AT gouveiaalinemaciel riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy
AT depaivaclarainacio riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy
AT segallavictoriachechetto riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy
AT baenacristinapellegrino riskfactorsforcognitivedeclineintype2diabetesmellituspatientsinbrazilaprospectiveobservationalstudy